Latest filing published 21 May 2025 for INOVIO PHARMACEUTICALS, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Simon X. Benito span 2 companies, the busiest being Inovio Pharmaceuticals, Inc. and Durect Corp. In total, 38 filings cover trades dated from 14 December 2006 to 21 May 2025.
Both buying and selling appear: 6 purchases worth €163k, against 11 sales worth €312k. Taken together, the sales exceed the purchases by €148k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 21 option exercises.
A typical purchase (the median) is worth €18k.
The record was last updated on 21 May 2025 with an option exercise in Inovio Pharmaceuticals, Inc. The most recent open-market purchase was published on 9 December 2021, 1,780 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations